Rapid attenuation of anti-SARS-CoV-2 antibodies in patients with musculoskeletal diseases in whom intensive immunosuppressive therapies were reinitiated after COVID-19: comment on the article by Curtis et al.
作者信息
Okamoto Masashi, Kawada Shoji, Shimagami Hiroshi, Fujii Naoko, Matsukawa Kazuki, Ishikawa Nachi, Kawamoto Keisuke, Higa Shinji, Ishida Yutaka, Ogata Atsushi, Yamaguchi Yuta, Morita Takayoshi, Kato Yasuhiro, Kumanogoh Atsushi
机构信息
Daini Osaka Police Hospital and Osaka University Graduate School of Medicine.
Daini Osaka Police Hospital.
出版信息
Arthritis Rheumatol. 2022 Apr;74(4):726-728. doi: 10.1002/art.42003. Epub 2022 Feb 25.
Abstract
摘要
相似文献
1
Rapid attenuation of anti-SARS-CoV-2 antibodies in patients with musculoskeletal diseases in whom intensive immunosuppressive therapies were reinitiated after COVID-19: comment on the article by Curtis et al.新型冠状病毒肺炎后重新开始强化免疫抑制治疗的肌肉骨骼疾病患者体内抗新型冠状病毒2抗体的快速衰减：对柯蒂斯等人文章的评论
Arthritis Rheumatol. 2022 Apr;74(4):726-728. doi: 10.1002/art.42003. Epub 2022 Feb 25.
2
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.风湿与肌肉骨骼疾病患者感染 SARS-CoV-2 及接种 SARS-CoV-2 疫苗的风险和预后：一项系统文献综述，旨在为 EULAR 建议提供信息。
Ann Rheum Dis. 2022 Mar;81(3):422-432. doi: 10.1136/annrheumdis-2021-221575. Epub 2021 Dec 7.
3
Low levels of anti-SARS-CoV-2 antibodies after vaccination in rituximab-treated patients: comment on the article by Simon et al.
Arthritis Rheumatol. 2022 May;74(5):908-909. doi: 10.1002/art.42011. Epub 2022 Apr 5.
4
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对单剂SARS-CoV-2 mRNA疫苗的抗体反应。
Ann Rheum Dis. 2021 Aug;80(8):1098-1099. doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.
5
Letter to the editor RE: Lake et al., 2022 comment on Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'.致编辑的信 回复：莱克等人，2022年对富尔福德等人，2021年《一种用于检测抗SARS-CoV-2中和抗体的即时侧流检测法》的评论
EBioMedicine. 2022 Mar;77:103899. doi: 10.1016/j.ebiom.2022.103899. Epub 2022 Mar 9.
6
Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli .对Smerilli所著《关于“风湿性和肌肉骨骼疾病患者对SARS-CoV-2疫苗的犹豫态度：给风湿病学家的信息”的通信》的回复
Ann Rheum Dis. 2021 Oct;80(10):e169. doi: 10.1136/annrheumdis-2021-220612. Epub 2021 May 7.
7
Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany.儿童和青少年风湿性肌肉骨骼疾病患者感染 SARS-CoV-2 的临床表现和结局：来自德国国家儿科风湿病数据库的数据。
RMD Open. 2021 Jul;7(2). doi: 10.1136/rmdopen-2021-001687.
8
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.风湿性和肌肉骨骼疾病患者接种两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗后无体液免疫反应：病例系列
Ann Intern Med. 2021 Sep;174(9):1332-1334. doi: 10.7326/M21-1451. Epub 2021 May 25.
9
Post-COVID syndrome. A case series and comprehensive review.新冠后综合征。病例系列与综合综述。
Autoimmun Rev. 2021 Nov;20(11):102947. doi: 10.1016/j.autrev.2021.102947. Epub 2021 Sep 10.
10
COVID-19 in an adolescent with aplastic anemia undergoing immunosuppressive therapy: A case report and details of antibody testing for SARS-CoV-2.一名正在接受免疫抑制治疗的再生障碍性贫血青少年的COVID-19感染：病例报告及SARS-CoV-2抗体检测详情
Pediatr Blood Cancer. 2022 Feb;69(2):e29332. doi: 10.1002/pbc.29332. Epub 2021 Sep 5.
引用本文的文献
1
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy.标准剂量和第三剂 SARS-CoV-2 疫苗接种在接受免疫抑制治疗患者中的免疫原性和安全性。
Arthritis Rheumatol. 2022 Aug;74(8):1321-1332. doi: 10.1002/art.42153. Epub 2022 Jun 29.
本文引用的文献
1
Castleman disease and TAFRO syndrome.卡斯尔曼病和 TAFRO 综合征。
Ann Hematol. 2022 Mar;101(3):485-490. doi: 10.1007/s00277-022-04762-6. Epub 2022 Jan 19.
2
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.美国风湿病学会关于风湿和肌肉骨骼疾病患者 COVID-19 疫苗接种的指南：第 3 版。
Arthritis Rheumatol. 2021 Oct;73(10):e60-e75. doi: 10.1002/art.41928. Epub 2021 Aug 4.
3
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者接种三剂mRNA新冠疫苗
N Engl J Med. 2021 Aug 12;385(7):661-662. doi: 10.1056/NEJMc2108861. Epub 2021 Jun 23.
4
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.BNT162b2 mRNA COVID-19 疫苗在成年自身免疫性炎症性风湿病患者和普通人群中的免疫原性和安全性：一项多中心研究。
Ann Rheum Dis. 2021 Oct;80(10):1330-1338. doi: 10.1136/annrheumdis-2021-220647. Epub 2021 Jun 14.
5
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者接种第三剂新冠病毒疫苗的安全性和免疫原性：病例系列
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
6
Immune memory in individuals with COVID-19.新冠病毒感染者体内的免疫记忆
Nat Cell Biol. 2021 Jun;23(6):582-584. doi: 10.1038/s41556-021-00689-8.
7
A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States.美国基于人群的新冠病毒抗体血清阳性寿命分析。
EClinicalMedicine. 2021 Jun;36:100902. doi: 10.1016/j.eclinm.2021.100902. Epub 2021 May 24.
8
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease.甲氨蝶呤会削弱免疫介导的炎症性疾病患者对BNT162b2 mRNA新冠疫苗的免疫原性。
Ann Rheum Dis. 2021 Oct;80(10):1339-1344. doi: 10.1136/annrheumdis-2021-220597. Epub 2021 May 25.
9
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort.在一项单中心队列研究中，慢性炎症性疾病和免疫抑制治疗患者的抗 SARS-CoV-2 mRNA 疫苗的免疫原性和安全性。
Ann Rheum Dis. 2021 Oct;80(10):1306-1311. doi: 10.1136/annrheumdis-2021-220272. Epub 2021 Mar 24.
10
A minimal common outcome measure set for COVID-19 clinical research.用于 COVID-19 临床研究的最小通用结局指标集。
Lancet Infect Dis. 2020 Aug;20(8):e192-e197. doi: 10.1016/S1473-3099(20)30483-7. Epub 2020 Jun 12.
Zotero 插件